Jacob Meredith, DO
Psychiatry · Louisville, KYNPI 1235766643
Payments from drug & device makers
Across 129 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$455
- Axsome Therapeutics, Inc.$312
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$269
- Lundbeck LLC$203
- Inari Medical, Inc.$200
- Teva Pharmaceuticals USA, Inc.$191
- plus $824 from 10 others
What the payments were for
- Food & beverage$2,25492%
- Education$2008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $455 |
| Axsome Therapeutics, Inc. | 19 | $312 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $269 |
| Lundbeck LLC | 6 | $203 |
| Inari Medical, Inc. | 1 | $200 |
| Teva Pharmaceuticals USA, Inc. | 10 | $191 |
| Alkermes, Inc. | 9 | $189 |
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| Johnson & Johnson | 6 | $137 |
| Neurocrine Biosciences, Inc. | 7 | $127 |
| Indivior Inc. | 4 | $80 |
| Bioxcel Therapeutics, Inc. | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Bausch Health US, LLC | 2 | $34 |
| Tris Pharma Inc | 1 | $24 |
| Biogen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,454 in reported general payments places this provider in the 75th percentile of 348 psychiatry providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium ErDivalproex Sodium | 21 | $2,385 |
| Aripiprazole | 41 | $2,302 |
| Quetiapine Fumarate | 69 | $1,543 |
| Olanzapine | 15 | $1,538 |
| Clozapine | 14 | $622 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $583 |
| Buspirone Hcl | 28 | $546 |
| Lurasidone Hcl | 11 | $475 |
| Clonazepam | 24 | $473 |
| Sertraline Hcl | 51 | $417 |
| Duloxetine Hcl | 21 | $346 |
| Paroxetine Hcl | 20 | $334 |
| Fluoxetine Hcl | 29 | $322 |
| Trazodone Hcl | 41 | $315 |
| Bupropion XlBupropion Hcl | 29 | $224 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Louisville
- Rifaat El-MallakhLouisville$1.7M
- Robert StewartLouisville$651K
- Ali FarooquiLouisville$393K
- Stephanie HallLouisville$106K
- Kelly ClarkLouisville$14K
- Michael HarrisLouisville$13K
- Yelena VaninaLouisville$12K
- Mohamed KhodeirLouisville$9K
- Kevin BaysLouisville$9K
- Terry HaganLouisville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.